The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens

Journal of Virological Methods

Volumn 142, Issue 1-2, 2007, Pages 226-230

  Woo, Yin Ling ^a,b   Damay, Isabelle ^a   Stanley, Margaret ^a   Crawford, Robin ^b   Sterling, Jane ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Archival tissue; Human papillomavirus typing; Linear Array; Multiple HPV infection

Indexed keywords

ACCURACY; ARTICLE; ASSAY; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA MICROARRAY; GENOTYPE; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; UTERINE CERVIX; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CRYOPRESERVATION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VULVA; VULVAR NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 34247100181     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.029     Document Type: Article

References (14)

1. Baldwin P.J., van der Burg S.H., Boswell C.M., Offringa R., Hickling J.K., Dobson J., Roberts J.S., Latimer J.A., Moseley R.P., Coleman N., Stanley M.A., and Sterling J.C. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin. Cancer Res. 9 (2003) 5205-5213
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., and Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer. Inst. 87 (1995) 796-802
3. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1157-1164
4. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 (2003) 63-73
5. Coutlee F., Gravitt P., Kornegay J., Hankins C., Richardson H., Lapointe N., Voyer H., and Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40 (2002) 902-907
6. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76 Pt 4 (1995) 1057-1062
7. Hildesheim A., Schiffman M.H., Gravitt P.E., Glass A.G., Greer C.E., Zhang T., Scott D.R., Rush B.B., Lawler P., Sherman M.E., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169 (1994) 235-240
8. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
9. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., and Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35 (1997) 1304-1310
10. Remmerbach T.W., Brinckmann U.G., Hemprich A., Chekol M., Kuhndel K., and Liebert U.G. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J. Clin. Virol. 30 (2004) 302-308
11. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., and Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324 (1986) 163-166
12. Stevens M.P., Garland S.M., and Tabrizi S.N. Human papillomavirus genotyping using a modified linear array detection protocol. J. Virol. Methods 135 (2006) 124-126
13. Stevens M.P., Tabrizi S.N., Quinn M.A., and Garland S.M. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int. J. Gynecol. Cancer 16 (2006) 1017-1024
14. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19